BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1238 related articles for article (PubMed ID: 27464484)

  • 1. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
    Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U
    Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging techniques for ANCA detection in vasculitis.
    Csernok E; Moosig F
    Nat Rev Rheumatol; 2014 Aug; 10(8):494-501. PubMed ID: 24890776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key advances in the clinical approach to ANCA-associated vasculitis.
    Kallenberg CG
    Nat Rev Rheumatol; 2014 Aug; 10(8):484-93. PubMed ID: 24980139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANCA associated vasculitis (AAV): a review for internists.
    Yaseen K; Mandell BF
    Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
    Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
    Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.
    Trivioli G; Marquez A; Martorana D; Tesi M; Kronbichler A; Lyons PA; Vaglio A
    Nat Rev Rheumatol; 2022 Oct; 18(10):559-574. PubMed ID: 36109667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
    Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
    Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis.
    Walker BS; Peterson LK; Koening C; White SK; Schmidt RL; Tebo AE
    Autoimmun Rev; 2022 Jun; 21(6):103100. PubMed ID: 35452854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives.
    Pecher AC; Henes M; Henes JC
    Arch Gynecol Obstet; 2023 Aug; 308(2):379-385. PubMed ID: 36104505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
    Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
    Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenesis of ANCA-Associated Vasculitis.
    Kronbichler A; Lee KH; Denicolò S; Choi D; Lee H; Ahn D; Kim KH; Lee JH; Kim H; Hwang M; Jung SW; Lee C; Lee H; Sung H; Lee D; Hwang J; Kim S; Hwang I; Kim DY; Kim HJ; Cho G; Cho Y; Kim D; Choi M; Park J; Park J; Tizaoui K; Li H; Smith L; Koyanagi A; Jacob L; Gauckler P; Shin JI
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
    Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
    PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
    Holle JU
    Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
    [No Abstract]   [Full Text] [Related]  

  • 19. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
    Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ
    Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.